Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status - The Economic Times
Two experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received 'fast track' designation from the U.S. drug regulator, the companies said on Monday.